5 Stocks Pushing The Health Services Industry Downward

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 39 points (-0.2%) at 16,431 as of Monday, Jan. 6, 2014, 11:55 AM ET. The NYSE advances/declines ratio sits at 1,317 issues advancing vs. 1,618 declining with 151 unchanged.

The Health Services industry currently sits down 0.2% versus the S&P 500, which is down 0.3%. On the negative front, top decliners within the industry include Air Methods ( AIRM), down 6.0%, UnitedHealth Group ( UNH), down 1.0%, HCA Holdings ( HCA), down 0.9% and Covidien ( COV), down 0.6%.

TheStreet would like to highlight 5 stocks pushing the industry lower today:

5. Universal Health Services ( UHS) is one of the companies pushing the Health Services industry lower today. As of noon trading, Universal Health Services is down $1.41 (-1.7%) to $80.10 on light volume. Thus far, 156,268 shares of Universal Health Services exchanged hands as compared to its average daily volume of 723,300 shares. The stock has ranged in price between $80.02-$81.94 after having opened the day at $81.64 as compared to the previous trading day's close of $81.51.

Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, behavioral health centers, surgical hospitals, ambulatory surgery centers, and radiation oncology centers. Universal Health Services has a market cap of $7.3 billion and is part of the health care sector. The company has a P/E ratio of 15.3, below the S&P 500 P/E ratio of 17.7. Shares are up 0.3% year to date as of the close of trading on Friday. Currently there are 10 analysts that rate Universal Health Services a buy, no analysts rate it a sell, and 4 rate it a hold.

TheStreet Ratings rates Universal Health Services as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, compelling growth in net income, revenue growth and notable return on equity. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Universal Health Services Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

4. As of noon trading, C.R. Bard ( BCR) is down $2.58 (-2.0%) to $128.55 on heavy volume. Thus far, 678,062 shares of C.R. Bard exchanged hands as compared to its average daily volume of 567,400 shares. The stock has ranged in price between $128.39-$130.24 after having opened the day at $128.83 as compared to the previous trading day's close of $131.13.

C. R. Bard, Inc. designs, manufactures, packages, distributes, and sells medical, surgical, diagnostic, and patient care devices worldwide. C.R. Bard has a market cap of $10.3 billion and is part of the health care sector. The company has a P/E ratio of 73.7, above the S&P 500 P/E ratio of 17.7. Shares are down 2.1% year to date as of the close of trading on Friday. Currently there are 5 analysts that rate C.R. Bard a buy, 1 analyst rates it a sell, and 9 rate it a hold.

TheStreet Ratings rates C.R. Bard as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations, largely solid financial position with reasonable debt levels by most measures, expanding profit margins and solid stock price performance. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full C.R. Bard Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

3. As of noon trading, Hologic ( HOLX) is down $0.56 (-2.5%) to $21.63 on light volume. Thus far, 1.4 million shares of Hologic exchanged hands as compared to its average daily volume of 4.5 million shares. The stock has ranged in price between $21.58-$22.04 after having opened the day at $21.89 as compared to the previous trading day's close of $22.19.

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women. Hologic has a market cap of $6.0 billion and is part of the health care sector. Shares are down 0.7% year to date as of the close of trading on Friday. Currently there are 7 analysts that rate Hologic a buy, 1 analyst rates it a sell, and 11 rate it a hold.

TheStreet Ratings rates Hologic as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, increase in stock price during the past year and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and weak operating cash flow. Get the full Hologic Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

2. As of noon trading, Humana ( HUM) is down $1.03 (-1.0%) to $100.73 on average volume. Thus far, 858,662 shares of Humana exchanged hands as compared to its average daily volume of 1.2 million shares. The stock has ranged in price between $99.96-$102.38 after having opened the day at $102.30 as compared to the previous trading day's close of $101.76.

Humana Inc., a health care company, offers a range of insurance products, and health and wellness services that incorporate an integrated approach to lifelong well-being. The company operates in three segments: Retail, Employer Group, and Healthcare Services. Humana has a market cap of $16.0 billion and is part of the health care sector. The company has a P/E ratio of 11.3, below the S&P 500 P/E ratio of 17.7. Shares are down 1.4% year to date as of the close of trading on Friday. Currently there are 12 analysts that rate Humana a buy, no analysts rate it a sell, and 8 rate it a hold.

TheStreet Ratings rates Humana as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, attractive valuation levels and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Humana Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

1. As of noon trading, Aetna ( AET) is down $0.38 (-0.6%) to $67.47 on light volume. Thus far, 772,858 shares of Aetna exchanged hands as compared to its average daily volume of 2.9 million shares. The stock has ranged in price between $67.16-$68.34 after having opened the day at $68.18 as compared to the previous trading day's close of $67.85.

Aetna Inc. operates as a diversified health care benefits company in the United States. The company operates in three segments: Health Care, Group Insurance, and Large Case Pensions. Aetna has a market cap of $24.8 billion and is part of the health care sector. The company has a P/E ratio of 13.7, below the S&P 500 P/E ratio of 17.7. Shares are down 1.1% year to date as of the close of trading on Friday. Currently there are 11 analysts that rate Aetna a buy, no analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates Aetna as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, attractive valuation levels, good cash flow from operations and increase in net income. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Aetna Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you are interested in one of these 5 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

null

More from Markets

McKesson Internal Review Clears Senior Management of Wrongdoing on Opioids

McKesson Internal Review Clears Senior Management of Wrongdoing on Opioids

Starbucks Surprises Wall Street With U.S. Sales Up a Paltry 2%

Starbucks Surprises Wall Street With U.S. Sales Up a Paltry 2%

Dow Jumps 238 Points as S&P 500, Nasdaq Also Climb

Dow Jumps 238 Points as S&P 500, Nasdaq Also Climb

Why Nashville, Denver, LA Should Reconsider Bids for Amazon HQ2

Why Nashville, Denver, LA Should Reconsider Bids for Amazon HQ2

3 Hot Reads From TheStreet's Top Premium Columnists

3 Hot Reads From TheStreet's Top Premium Columnists